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Model	parameters Health	state Parameter Source	/	Method Distribution
Annual	prob	ACT T2D 0.002	(0.002) Joseph,	et	al.	24 Beta
	 CHD 0.008	(0.0005) Frew,	et	al.11 Beta
	 STR 0.011	(0.0031) Sattelmair,	et	al.25 Beta
	 CRC 0.003	(0.003) Frew,	et	al.11 Beta
	 BRC 0.011	(0.001) Frew,	et	al.11 Beta
6
	 BRC 0.011	(0.001) Frew,	et	al.11 Beta




	 FRA 0.023	(0.023) Fried,	et	al.	27 Beta
RR	INA T2D 1.700	(1.7) Roux,	et	al.	15 LogNormal
	 CHD 1.500	(1.5) Roux,	et	al.	15 LogNormal
	 STR 1.300	(1.3) Roux,	et	al.	15 LogNormal
	 CRC 1.600	(1.6) Roux,	et	al.	15 LogNormal
	 BRC 1.300	(1.3) Roux,	et	al.	15 LogNormal
	 DEP 1.150	(1.15) Meng	and	D'Arcy	28 LogNormal
	 FRA 1.429	(1.43) McPhee,	et	al.	29 LogNormal
RR	INS T2D 1.525	(1.52) Linear	interpolation LogNormal
	 CHD 1.375	(1.137) Linear	interpolation LogNormal
	 STR 1.225	(1.225) Linear	interpolation LogNormal
	 CRC 1.450	(1.45) Linear	interpolation LogNormal
	 BRC 1.225	(1.225) Linear	interpolation LogNormal
	 DEP 1.113	(1.11) Linear	interpolation LogNormal
	 FRA 1.321	(1.32) Linear	interpolation LogNormal
RR	MOD T2D 1.292	(1.29) Linear	interpolation LogNormal
	 CHD 1.208	(1.208) Linear	interpolation LogNormal
	 STR 1.125	(1.125) Linear	interpolation LogNormal
	 CRC 1.250	(1.25) Linear	interpolation LogNormal
	 BRC 1.125	(1.125) Linear	interpolation LogNormal
	 DEP 1.063	(1.063) Linear	interpolation LogNormal
	 FRA 1.179	(1.179) Linear	interpolation LogNormal
RR	IMD T2D 1.250	(0.041) Sharma,	et	al.	30 LogNormal
	 CHD 1.294	(1.29) Bajekal,	et	al.	31 LogNormal
	 STR 1.400	(1.4) Bray,	et	al.	32 LogNormal
	 CRC 1.100	(1.1) Cancer	Research	UK
33
LogNormal
	 BRC 0.860	(0.86) Cancer	Research	UK
33
LogNormal
	 DEP 1.170	(0.296) Walters,	et	al.	34 LogNormal
	 FRA 1.100	(0.11) Curtis,	et	al.	35 LogNormal
RR	death T2D 1.850	(0.332) Nwaneri,	et	al.	36 LogNormal
	 CHD 1.900	(0.161) Vlachopoulos,	et	al.
37
LogNormal
	 STR 1.900	(0.161) Vlachopoulos,	et	al.
37
LogNormal
	 CRC 1.449	(1.45) Cancer	Australia	38 LogNormal
	 BRC 1.320	(0.041) Christiansen,	et	al.
39
LogNormal
	 DEP 1.520	(0.036) Cuijpers,	et	al.	40 LogNormal
	 FRA 2.700	(0.74) Kulmala,	et	al.	41 LogNormal
Utility	decrements T2D 0.062	(0.06) Sullivan	and
Ghushchyan	42
Gamma
	 CHD 0.056	(0.06) Gulliford,	et	al.	14 Gamma
	 STR 0.101	(0.101) Gulliford,	et	al.	14 Gamma
	 CRC 0.038	(0.038) Gulliford,	et	al.	14 Gamma
	 BRC 0.015	(0.015) Sullivan,	et	al.	43 Gamma
	 DEP 0.130	(0.13) Gulliford,	et	al.	14 Gamma






	 INS 0.985	(0.0218) HSE	2014	data
analysis
Beta
	 MOD 0.997	(0.0223) HSE	2014	data
analysis
Beta
	 ACT 0.982	(0.0219) HSE	2014	data
analysis
Beta







	 INS 0.979	(0.0228) HSE	2014	data
analysis
Beta
	 MOD 0.981	(0.0239) HSE	2014	data
analysis
Beta





T2D £	1,363 Frew,	et	al.11 Fixed
	 CHD1 £	3,489 Frew,	et	al.11 Fixed
	 CHD2 £	105 Frew,	et	al.11 Fixed
	 STR1 £	9,630 Frew,	et	al.11 Fixed
	 STR2 £	2,396 Frew,	et	al.11 Fixed
	 CRC £	9,999 Frew,	et	al.11 Fixed
	 BRC £	9,091 Frew,	et	al.11 Fixed
	 DEP £	139 Thomas	and	Morris
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Fixed












































































































































LLGA £	3,557.39 3.0273 -£	61.29 0.02789 Dominant £	619
no	LLGA £	3,618.68 2.9994
Figure	2	shows	one	thousand	model	iterations	of	the	cost	and	QALY	joint	density	plotted	on	a	cost-
effectiveness	plane,	comparing	LLGA	intervention	to	a	no-intervention	scenario	(set	as	the	origin),
under	base-case	assumptions.	Looking	at	the	distribution	of	cost	and	QALY	pairs,	the	majority	fall
below	the	WTP	lower	bound,	indicating	that	there	is	a	high	probability	of	LLGA	being	the	optimal
alternative.	Figure	3	shows	the	probability	of	LLGA	being	cost-effective,	across	a	range	of	WTP
thresholds.	The	cost-effectiveness	acceptability	curve	(CEAC)	did	not	cut	the	y-axis	at	zero	(i.e.	55%)
indicating	that	part	of	the	joint	density	involved	cost-savings19.	Reflecting	what	was	displayed	in
Fig.	2,	there	is	a	high	probability	(95%)	of	LLGA	being	the	optimal	strategy	was	found	when
considering	a	£20,000	threshold.
Discussion
Main	findings
Results	from	this	cost-utility	analysis	indicate	that	LLGA	is	likely	to	be	cost-effective	under	base-case
assumptions.	The	net	benefits	of	implementing	LLGA	increase	as	a	longer	time	horizon	is	considered.
Scenario	analyses	also	show	that	identification	of	the	optimal	strategy	is	highly	dependent	on
variations	to	the	effectiveness	measure	and	key	structural	elements	regarding	the	sustainability	of
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the	intervention	effect	over	time	and	assumed	mechanisms	of	survey	non-response.
Comparison	with	other	studies
This	study	can	be	placed	within	the	currently	limited	economic	evaluation	literature	on	population-
level	promotion	of	PA.	In	particular,	the	economic	evaluation	conducted	to	assess	the	cost-
effectiveness	of	the	BeActive	programme11.	This	represents	the	main	comparison	study.	LLGA
mirrored	the	BeActive	intervention	modality,	except	that	LLGA	was	offered	only	in	City	Council	leisure
centres	located	in	the	most	deprived	areas	of	the	city.	This	afforded	an	opportunity	to	test	the	cost-
effectiveness	of	providing	universal	access	to	free	off-peak	leisure	centre-based	sessions	in	another
similar	setting.	For	BeActive,	base-case	cost-effectiveness	estimates	were	not	dissimilar	from	those
reported	here,	with	an	estimated	£400	incremental	cost	per	QALY	gained.	This	finding	supports	the
hypothesis	that	this	type	of	population-level	intervention	represents	good	value	for	money	also	in	the
short	term,	and	even	when	the	offer	is	proportionate	to	attract	hard	to	reach	groups.	By	contrast	with
this	study,	BeActive	appeared	to	be	cost-effective	even	under	the	most	conservative	assumptions,
though	no	further	details	were	reported.	Another	comparable	study	simulated	the	implementation	of
a	primary	care-based	universal	intervention	and	found	a	64.7%	probability	of	the	intervention	being
cost-effectiveness	at	a	WTP	threshold	of	£30,000.14	One	possible	explanation	for	this	difference	in
results	is	that,	in	that	study,	utility	gains	were	accumulated	only	as	a	function	of	reduction	in	disease
incidence	and	no	utility	gains	were	assigned	from	transitions	to	higher	PA	levels.	Nevertheless,
although	some	of	the	economic	evaluation	methods	used	in	the	present	analysis	were	aligned	with
those	studies	(e.g.	perspective,	short	time	horizon),	differences	in	the	structures	and	parameters	of
the	economic	models	limited	the	ability	to	directly	compare	our	findings.
Strengths	and	limitations
To	the	best	of	our	knowledge,	this	represents	the	first	cost-utility	analysis	of	a	proportionate	universal
programme	to	promote	free	off-peak	leisure	centre-based	exercise	in	the	general	population.	The
programme	is	relatively	easy	to	incorporate	into	currently	operating	public	leisure	centres	(off-peak
sessions),	and	therefore	this	intervention	has	the	potential	to	be	replicated	in	other	comparable
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settings	(i.e.	local	City	Councils	in	the	UK).	As	a	result,	this	makes	the	evidence	generated	by	this
analysis	particularly	important	for	decision-makers	that	may	be	interested	in	evaluating	the	impact	of
implementing	this	type	of	intervention	in	the	future.
The	study	is	however	subject	to	a	number	of	limitations.	In	particular	were	the	lack	of	experimental
design,	a	non-research	led	data	collection	and	handling	process	and	restrictions	imposed	in	terms	of
further	data	collection	on	residents/participants.	This	meant	making	the	validity	of	effectiveness
results	depend	on	the	plausibility	of	a	parallel	trend	assumption,	representativeness	of	the	sample	of
participants	providing	full	outcome	data,	as	well	as	on	untested	measures	of	PA	behaviour	change
which	in	turn	relied	on	self-report.	Previous	similar	studies	share	these	limitations	that	cannot	be
overcome	retrospectively	and	are	likely	to	characterise	large-scale	programmes.	Furthermore,	while	a
sub-group	analysis	was	conducted	to	account	for	heterogeneous	effects,	one	of	the	objective	of	public
health	decision-makers	is	to	reduce	existing	health	inequality,	which,	due	to	resource	constraints,	was
not	possible	to	ascertain	within	this	study.
Application	of	the	QALY	as	the	consequence	considered	in	the	evaluation	restricted	the	evaluative
space	accordingly,	therefore	excluding	non-health	effects	potentially	generated	by	the	intervention
(e.g.	increased	work-related	productivity20).	However,	in	line	with	previous	models11	15	21,	the
decision-analytic	model	used	for	economic	evaluation	of	LLGA	was	designed	to	accumulate	utility
gains/losses	as	a	result	of	changes	in	PA	state.
A	de	novo	decision-analytic	model	was	developed	building	on	previous	models,	by	incorporating	a
continuous-time	structure	which	allowed	for	testing	the	assumption	related	to	the	sustainability	of
behaviour	change	over	time.	Nonetheless,	this	analysis	still	relied	upon	other	structural	assumptions
relating	to	a	fully	elastic	dose-response	relationship	between	changes	in	PA	and	health,	compensatory
or	synergistic	effects	potentially	occurred	on	the	path	to	health	improvement	(e.g.	changes	in	dietary
habits),	increased	health	expenditure	from	extended	life	expectancy,	and	adverse	events	(e.g.
injuries)	which	were	not	formally	taken	into	account.	Nevertheless,	unlike	previous	models,	negative
intervention	effects	were	captured	informally	by	allowing	the	four	PA	states	to	move	freely	between
one	another.
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Further,	these	results,	like	those	presented	in	previous	similar	studies,	rely	on	a	set	of	structural
assumptions	which	have	not	been	verified	yet	and	have	the	potential	to	impact	identification	of	the
optimal	intervention.	In	particular,	although	the	decision-analytic	model	used	for	this	economic
evaluation	allows	for	“natural”	transitions	between	PA	states	to	be	captured,	due	to	lack	of	relevant
data,	PA	states	were	assumed	to	be	stable	over	time	in	absence	of	the	intervention.	However,	this
may	not	always	be	necessarily	the	case,	especially	in	the	short	term	22	and	during	sensitive	life
phases	(e.g.	retirement	23).	Furthermore,	since	the	effects	of	changes	in	PA	on	chronic	disease	are
likely	to	vary	between	conditions	and	depend	on	personal	characteristics,	as	well	as	on	their
magnitude/persistence,	population-level	monitoring	studies	should	deal	with	these	aspects.
In	addition,	the	impact	of	an	intervention	like	LLGA	is	likely	to	vary	not	only	between	individuals	and
over	time,	but	also	on	whose	economic	perspective	is	taken.	In	this	and	previous	studies11	14,	costs
and	benefits	(QALYs)	falling	on	the	health	care	sector	only	were	considered.	However,	results	are
likely	to	change	when	a	local	public	health	agency	viewpoint	is	taken.	As	the	body	administering	and
hosting	the	intervention,	the	opportunity	cost	by	the	Local	Authority	may	not	coincide	with	the	budget
expenditure.	Potential	spill-overs	from	increased	numbers	of	paying	members	or	reductions	in
member	retention	due	to	the	intervention	might	have	occurred.
Implications	for	future	research
The	results	presented	here	contribute	new	economic	information	regarding	the	value	for	money	of
universal	programmes	to	reduce	physical	inactivity	in	the	general	population.	A	number	of	limitations
have	been	noted	with	the	analysis	reported	here,	many	of	which	relate	to	the	paucity	of	data	to
inform	such	analysis	and	a	lack	of	consensus	on	methodological	approaches.	Future	work	should
focus	on	better	data	collection	and	assessing	the	value	for	money	of	this	type	of	population-level
programmes	to	inform	decisions	that	often	are	made	outside	the	health	care	sector.
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